Briefing
Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer.
A prospective biomarker trial found that longitudinal plasma circulating tumor HPV DNA during surveillance detected clinical recurrence in nonmetastatic HPV-associated oropharyngeal cancer.
- Design: Evidence level 2
- Assay: ctHPVDNA
Journal of Clinical OncologyPubMed 32017652DOI 10.1200/JCO.19.02444